NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
key details
| Status | complete |
|---|---|
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Procedure | open |
| OCID | ocds-h6vhtk-051c98 |
Awards (24)
This procurement was awarded to 24 suppliers. Values shown are per-award; the notice total is ·.
| Supplier | Value | Date | Status |
|---|---|---|---|
| ACCORD-UK LTD shared | · | · | active |
| AMGEN LIMITED shared | · | · | active |
| AVENTIS PHARMA LIMITED t-a Sanofi shared | · | · | active |
| BAYER PLC shared | · | · | active |
| BIOGEN IDEC LIMITED shared | · | · | active |
| CHUGAI PHARMA LIMITED shared | · | · | active |
| CST PHARMA LIMITED shared | · | · | active |
| ELI LILLY & COMPANY LTD shared | · | · | active |
| GEDEON RICHTER (UK) LIMITED shared | · | · | active |
| GLAXOSMITHKLINE UK LIMITED shared | · | · | active |
| LABORATORIES JUVISE PHARMACEUTICALS shared | · | · | active |
| MERCK SERONO LIMITED shared | · | · | active |
| MILPHARM LIMITED shared | · | · | active |
| NAPP PHARMACEUTICALS LTD shared | · | · | active |
| NOVO NORDISK shared | · | · | active |
| ORIFARM UK LTD shared | · | · | active |
| PFIZER LIMITED shared | · | · | active |
| PHARMACOSMOS UK LTD shared | · | · | active |
| ROCHE PRODUCTS LIMITED shared | · | · | active |
| SANDOZ LIMITED shared | · | · | active |
| TEVA UK LIMITED shared | · | · | active |
| THORNTON & ROSS LIMITED shared | · | · | active |
| VIATRIS UK HEALTHCARE LTD shared | · | · | active |
| VIFOR PHARMA UK LTD shared | · | · | active |
description
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East.
Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.
Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
notice history
8 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 22 May 2025 | Pipeline notice (UK1) | Procurement Act 2023 | 024471-2025 |
| 3 Jun 2025 | Pipeline notice (UK1) | Procurement Act 2023 | 029473-2025 |
| 13 Jan 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 002508-2026 |
| 13 Mar 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 023102-2026 |
| 17 Mar 2026 | Tender notice (UK4) | Procurement Act 2023 | 023990-2026 |
| 23 Jun 2026 | Contract award (UK6) | Procurement Act 2023 | 058925-2026 |
| 9 Jul 2026 | Contract award (UK6) | Procurement Act 2023 | 064847-2026 |
| 21 Jul 2026 | Contract details (UK7) | Procurement Act 2023 | 068603-2026 |
more from NHS England
- Coaching services for trainee doctors, dentists and pharmacists · £36,000 · 30 Jul 2026
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
all contracts from this buyer →
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.